Executive Development Programme in Biotech IP for the C-Suite
-- ViewingNowThe Executive Development Programme in Biotech IP for the C-Suite is a certificate course designed to empower senior executives with a comprehensive understanding of intellectual property (IP) management in the biotechnology industry. This program is crucial in today's rapidly evolving biotech landscape, where IP rights can significantly impact a company's competitive advantage and market value.
6,774+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Biotech IP Strategy for C-Suite: Understanding the basics of intellectual property (IP) in the biotech industry, including patents, trademarks, and trade secrets. This unit will cover the development and implementation of a robust IP strategy to protect the company's assets and gain a competitive advantage.
⢠Biotech Patent Law: This unit will delve into the specifics of patent law as it relates to the biotech industry. Topics will include patent eligibility, patentability, and the application process. The unit will also cover patent enforcement strategies and the role of patent litigation in protecting IP rights.
⢠Biotech IP Licensing: This unit will cover the various types of IP licenses, including exclusive and non-exclusive licenses. The unit will also discuss the key terms of an IP license agreement, including royalties, duration, and territorial restrictions.
⢠Biotech IP Valuation: This unit will explore the various methods for valuing IP assets in the biotech industry. The unit will cover both qualitative and quantitative methods, including cost-based, market-based, and income-based approaches.
⢠Biotech IP Portfolio Management: This unit will cover best practices for managing a biotech company's IP portfolio. Topics will include IP due diligence, monitoring and enforcement, and the role of IP in M&A transactions.
⢠Biotech IP and Regulatory Strategy: This unit will discuss the intersection of IP and regulatory strategy in the biotech industry. The unit will cover topics such as data exclusivity, regulatory approval processes, and the role of IP in securing market exclusivity.
⢠Biotech IP and Research & Development: This unit will explore the role of IP in the research and development process in the biotech industry. Topics will include IP protection for novel compounds, methods, and technologies, as well as the use of IP to attract research funding and partnerships.
⢠Biotech IP and Marketing: This unit will cover the role of IP in marketing and branding efforts in the biotech industry. Topics will include
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
